Wednesday, July 1, 2026
ADVT 
National

PHAC eyeing COVID-19 variant evolution as fall resurgence looms

Darpan News Desk The Canadian Press, 18 Oct, 2022 01:44 PM
  • PHAC eyeing COVID-19 variant evolution as fall resurgence looms

OTTAWA — The national public health agency is preparing for "worst-case scenario" COVID-19 variants that can evade immunity, Canada's top doctor told members of Parliament Tuesday, as early signs point to a fall resurgence of the virus.

At the House of Commons health committee, Chief Public Health Officer Dr. Theresa Tam said the Public Health Agency of Canada is keeping a particularly careful eye on the evolution of Omicron variants, which are the most common subvariants in the country, along with any new mutations.

"We haven't detected any very extraordinary appearances as yet, but that is a scenario that we're planning ahead for," Tam said during her virtual appearance at the committee. 

In the early days of the pandemic, the virus would mutate in all sorts of ways because people did not have immunity from previous infections or vaccines.

Now, because the virus has been constrained, several subvariants of Omicron have begun to develop identical mutations — a phenomenon known as evolutionary convergence. 

"When there's broad population immunity, it puts pressure on the virus to find advantages, such as escaping our existing immunity," Tam said. 

The worst-case scenario, Tam said, is that eventually a variant will find a way to sidestep the effectiveness of vaccines and treatment with monoclonal antibodies. 

"We haven't detected one of those yet, but we need to be prepared for the potential," she said.

The COVID-19 situation in Canada has remained relatively steady as of the first week of October, even as the weather has cooled and students have returned to school. Early signs are beginning to show a potential resurgence, Tam said, with the number of hospitalizations increasing in some parts of the country.

In the meantime, only 18 per cent of eligible Canadians are up-to-date on their vaccinations with a two-dose primary series and a booster within the last six months, Tam said.

"The good news is that we do have these bivalent vaccines," which target both the original strain of COVID-19 and more recent offshoots, Tam said. So far about five per cent of eligible Canadians have received a bivalent shot. 

She said the agency is working on building momentum around those new vaccines to try to increase the number of people who get the shot this fall. 

But Tam took a barrage of criticism from Conservative members of the committee over her communication throughout the pandemic, as MPs charged that the public has "lost trust" in institutions like the public health agency.

If another really bad virus came along that required lockdowns and other measures, "Canadians wouldn't listen to you," Saskatchewan Conservative MP Randy Hoback said to Tam.

"They would say 'Never. We're never doing this again. We don't trust you, we don't listen to you.' And we'd see then the massive deaths that would be the result."

Alberta MP Laila Goodridge told Tam there was a disconnect between the public health agency's advice and what she hears about daily life in rural Canada, and suggested the chief public health officer visit those places in person.

Several MPs asked Tam whether there would be a post-mortem of Canada's COVID-19 response. Tam agreed it will be important to review and learn lessons from how the country handled the virus, but wouldn't comment on any specific plans.

"We've just been through the biggest pandemic of the current era and it is very important to take note of lessons learned and be as objective as we can," Tam said.  

"It's important to set us up well for our response going into the future, given that pandemics will occur again."

MORE National ARTICLES

Protective equipment still scarce for some nurses

Protective equipment still scarce for some nurses
While early indications showed the virus was spread by droplets that settled on surfaces, Silas, president of the Canadian Federation of Nurses, urged health authorities to learn from the SARS outbreak of 2003 and take the highest level of precaution.    

Protective equipment still scarce for some nurses

COVID-19 hospitalizations to surge: Tam

COVID-19 hospitalizations to surge: Tam
Though the rate of people who are hospitalized with Omicron is lower compared to the Delta variant, the forecast shows new daily hospital admissions will far exceed previous historical peaks due to the sheer number of cases.

COVID-19 hospitalizations to surge: Tam

Omicron upends mathematical models tracking COVID

Omicron upends mathematical models tracking COVID
Everything from who gets tested to who's most likely to contract the virus has changed with the latest wave of the pandemic, and that's posing distinct challenges for those who model its impact, says Caroline Colijn, an associate professor of mathematics at Simon Fraser University in British Columbia.

Omicron upends mathematical models tracking COVID

O'Toole opposes Quebec's plan to tax unvaccinated

O'Toole opposes Quebec's plan to tax unvaccinated
The Tory leader made his position known on Premier François Legault's proposal during a Facebook Liveevent late Thursday. Some of his MPs had already taken to social media to condemn the proposal as discriminatory, unethical and punishing to low-income earners.

O'Toole opposes Quebec's plan to tax unvaccinated

B.C. funds OD prevention in construction industry

B.C. funds OD prevention in construction industry
Sheila Malcolmson, the minister of mental health and addictions, says the program dubbed the Tailgate Toolkit was developed on Vancouver Island last year in partnership with people in the industry who have experience with illicit drug use.    

B.C. funds OD prevention in construction industry

Health Canada decision on Pfizer antiviral close

Health Canada decision on Pfizer antiviral close
Canadian health leaders and some premiers have been publicly pressuring Health Canada to greenlight the medication, which prevents the SARS-CoV-2 virus that causes COVID-19 from reproducing within a patient's body. Pfizer's clinical trial showed for high-risk patients it prevented hospitalizations by about 90 per cent.

Health Canada decision on Pfizer antiviral close